Bruker (BRKR)
(Delayed Data from NSDQ)
$65.88 USD
-2.45 (-3.59%)
Updated Aug 2, 2024 04:00 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BRKR 65.88 -2.45(-3.59%)
Will BRKR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BRKR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BRKR
What's in Store for These 4 MedTech Stocks in Q2 Earnings?
Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
BRKR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?
Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds
Bruker (BRKR) Expands in NMR Spectrometry With New FMP Collab
Other News for BRKR
Bruker Larger Than S&P 500 Component Paycom Software
Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast
Fidelity Mid-Cap Stock Fund Q2 2024 Review
Bruker Announces that Injunction Impacting NanoString?s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately
Bruker posts bond in Germany to suspend injunction hurting sales of CosMx SMI